Research Solutions CRO granted 80,000 restricted shares
Cohen Sefton reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Cohen Sefton reported acquisition or exercise transactions in this Form 4 filing.
Research Solutions, Inc. Chief Revenue Officer Cohen Sefton received a grant of 80,000 shares of restricted common stock valued at $2.29 per share as equity compensation. One‑third of these restricted stock awards vest on March 18, 2027, with the remainder vesting quarterly beginning March 31, 2027. Following this award, Sefton directly holds 359,933 shares of common stock.
Insider Trade Summary
Grant/Award: 80,000 shares
Grant/Award
1 txn
Insider
Cohen Sefton
Role
Chief Revenue Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 80,000 | $2.29 | $183K |
Holdings After Transaction:
Common Stock — 359,933 shares (Direct)
Footnotes (1)
- F1. Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on March 18, 2027 and 1/12th of the RSAs vest on the last day of each quarter beginning March 31, 2027 until fully vested.
Key Figures
Restricted stock grant: 80,000 shares
Grant value per share: $2.29 per share
Post-transaction holdings: 359,933 shares
+2 more
5 metrics
Restricted stock grant
80,000 shares
Grant of restricted common stock to CRO Cohen Sefton
Grant value per share
$2.29 per share
Value used for the 80,000-share restricted stock award
Post-transaction holdings
359,933 shares
Total common shares directly held by Cohen Sefton after grant
Initial vesting date
March 18, 2027
One-third of the restricted stock awards vest on this date
Quarterly vesting schedule
1/12 each quarter
Remaining RSAs vest quarterly from March 31, 2027 until fully vested
Key Terms
restricted stock, RSAs, vest, Chief Revenue Officer
4 terms
restricted stock financial
"Represents a grant of shares of restricted stock ("RSAs")."
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
RSAs financial
"Represents a grant of shares of restricted stock ("RSAs")."
vest financial
"1/3rd of the RSAs vest on March 18, 2027 and 1/12th of the RSAs vest on the last day of each quarter"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
Chief Revenue Officer financial
"Cohen Sefton is identified as Chief Revenue Officer."
A chief revenue officer is a top executive responsible for overseeing all aspects of generating income for a company, including sales, marketing, and customer relationships. They develop strategies to attract and retain customers, much like a coach guiding a team to score more points. Investors pay attention to this role because it directly influences the company's growth and profitability.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Research Solutions (RSSS) report for Cohen Sefton?
Research Solutions reported that Chief Revenue Officer Cohen Sefton received a grant of 80,000 shares of restricted common stock. The award is compensation, not an open‑market purchase, and increases his direct holdings to 359,933 shares of common stock after the transaction.
How do Cohen Sefton’s restricted stock awards in RSSS vest over time?
One‑third of Cohen Sefton’s restricted stock awards vest on March 18, 2027. The remaining two‑thirds vest in equal 1/12th installments on the last day of each quarter, starting March 31, 2027, until all 80,000 granted shares are fully vested.
Is Cohen Sefton’s Research Solutions (RSSS) transaction a market purchase or a compensation grant?
The transaction is a compensation grant of restricted stock awards, not a market purchase. The Form 4 identifies it with code “A” for grant or award, and a footnote clarifies it represents restricted stock with time‑based vesting conditions.
What role does Cohen Sefton hold at Research Solutions (RSSS) in this Form 4 filing?
Cohen Sefton is identified as Chief Revenue Officer of Research Solutions. The reported grant of 80,000 restricted shares reflects part of his equity‑based compensation as a senior executive, aligning his interests with the company’s long‑term stock performance.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates